ZFAS1 and nonpapillary renal cell carcinoma: Through targeting the miR-10a/SKA1 pathway, ZFAS1 knockdown was shown to decrease the growth and metastasis of ccRCC in biological tests, suggesting that it may provide a new therapeutic target or biomarker for the disease [15].